LB Pharmaceuticals Inc (LBRX)

LB Pharmaceuticals Statistics

Total Valuation

LBRX has a market cap or net worth of $602.62 million. The enterprise value is $291.81 million.

Market Cap	602.62M
Enterprise Value	291.81M

Important Dates

The next estimated earnings date is Thursday, June 25, 2026, before market open.

Earnings Date	Jun 25, 2026
Ex-Dividend Date	n/a

Share Statistics

LBRX has 25.30 million shares outstanding. The number of shares has increased by 10,035.57% in one year.

Current Share Class	25.30M
Shares Outstanding	25.30M
Shares Change (YoY)	+10,035.57%
Shares Change (QoQ)	+9,947.74%
Owned by Insiders (%)	0.61%
Owned by Institutions (%)	56.16%
Float	14.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.94
P/TBV Ratio	1.94
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 47.60, with a Debt / Equity ratio of 0.01.

Current Ratio	47.60
Quick Ratio	47.31
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-7.03%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$1.18M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, LBRX has paid $1,000 in taxes.

Income Tax	1,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	20.76
200-Day Moving Average	n/a
Relative Strength Index (RSI)	59.37
Average Volume (20 Days)	210,805

Short Selling Information

The latest short interest is 1.79 million, so 7.08% of the outstanding shares have been sold short.

Short Interest	1.79M
Short Previous Month	n/a
Short % of Shares Out	7.08%
Short % of Float	12.71%
Short Ratio (days to cover)	3.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.07M
Pretax Income	-18.80M
Net Income	-18.80M
EBITDA	-21.76M
EBIT	-22.07M
Earnings Per Share (EPS)	-$0.74

Balance Sheet

The company has $314.48 million in cash and $3.67 million in debt, with a net cash position of $310.81 million or $12.29 per share.

Cash & Cash Equivalents	314.48M
Total Debt	3.67M
Net Cash	310.81M
Net Cash Per Share	$12.29
Equity (Book Value)	310.22M
Book Value Per Share	12.26
Working Capital	309.75M

Cash Flow

In the last 12 months, operating cash flow was -$22.77 million and capital expenditures -$250,000, giving a free cash flow of -$23.02 million.

Operating Cash Flow	-22.77M
Capital Expenditures	-250,000
Free Cash Flow	-23.02M
FCF Per Share	-$0.91

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LBRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10,035.57%
Shareholder Yield	-10,035.57%
Earnings Yield	-3.12%
FCF Yield	-3.82%

Analyst Forecast

The average price target for LBRX is $49.00, which is 105.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$49.00
Price Target Difference	105.54%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1